Filana Therapeutics share price logo

Filana Therapeutics

NASDAQ: FLNA

$0.71

-0.05

(-6.81%)

as on

Filana Therapeutics Stock Performance

as on October 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.70
    $0.76
    downward going graph

    1.27%

    Downside

    7.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Filana Therapeutics share price movements today

Previous Close
$0.76
Open
$0.76
Volume
641.7K
Market Cap
$35.9M
Day's Low - High
$0.70 - $0.76

Filana Therapeutics Historical Returns

1 Month Return
+ 11.2 %
3 Month Return
-29.56 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Filana Therapeutics Stock Fundamentals & Key Indicators

Check Filana Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.9M

EPS (TTM)

-0.66

Dividend Yield

0.00%

PE Ratio (TTM)

-0.87

Industry PE ratio

-2.42

PEG Ratio

-0.01

Return On Equity TTM

-58.78%

Filana Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Filana Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Filana Therapeutics image
Filana Therapeutics
NA$35.9MNA-0.870.00%0.00%
Moderna image
Moderna
Neutral$90.3B-27.05%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$126.4B179.89%28.7886.04%0.00%
Regeneron image
Regeneron
Buy$77.5B43.94%19.0184.86%0.48%

Indian Investors' Interest in Filana Therapeutics Stock

Search interest for Filana Therapeutics Stock has increased by 1176% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1176% versus previous 30 day period

Filana Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-23
-18
-16
-15
-
-
-
-
0
0
Operating Income
-27
-22
-19
-61
-30
-29
-24
-11
-13
-9
EBITDA
-27
-22
-22
-66
-27
-30
-23
-10
-12
-9
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-25
-20
25
6
-27
-27
-23
-10
-12
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-25
-20
25
6
-27
-27
-23
-10
-12
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Filana Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-1
-3
-
-68
-89
-
0
Operating Income
-11
-6
-4
-6
-32
-80
-105
-141
-95
EBITDA
-11
-6
-4
-6
-32
-78
-104
-141
-90
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
1
1
1
0
Income Before Tax
-11
-6
-4
-6
-32
-76
-97
-24
-90
Income Tax Expense
0
-
-
-
-
-
-
-
-
Net Income
-11
-6
-4
-6
-32
-76
-97
-24
-90
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Filana Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Jun 2026
Net Income
-25
-20
25
6
-27
-27
-23
-10
-12
-8
Operating Cash Flow
-26
-22
-19
-18
-18
-61
-11
-6
-9
-3
Investing Cash Flow
0
0
-
0
0
0
-
0
0
0
Financing Cash Flow
0
1
22
101
-
0
0
-
0
0
Change in Cash
-26
-21
3
83
-18
-60
-11
-6
-10
-3

Filana Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-6
-4
-6
-32
-76
-97
-24
-90
Operating Cash Flow
-8
-4
-2
-5
-30
-77
-82
-116
-32
Investing Cash Flow
2
-
0
0
-22
-2
0
0
0
Financing Cash Flow
-
14
5
75
192
47
2
124
0
Change in Cash
-6
9
3
70
139
-32
-79
7
-33

Global Institutional Holdings in Filana Therapeutics

Check out the Institutions with significant holdings in Filana Therapeutics.

Funds
Holdings
Vanguard
4.27%
VANGUARD INDEX FUNDS
3.90%
Thomas E. Claugus
0.93%
Fidelity Concord Street Trust
0.87%
iShares
0.32%
See all

Filana Therapeutics News & Key Events

  • img

    Today's Timeline - 22 September

    Tue, 05:50 PM

    -

    Filana Therapeutics announces FDA lifted clinical hold on simufilam, allowing Phase 2a study in TSC-related epilepsy to proceed.

Insights on Filana Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, FLNA stock has moved up by 11.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.2% return, outperforming this stock by 251.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 771.4% return, outperforming this stock by 854.6%

About Filana Therapeutics

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
OrganisationFilana Therapeutics
Headquarters6801 N. Capital of Texas Highway, Austin, TX, 78731, US
IndustryBiotechnology
CEORichard Jon Barry

Key Management of Filana Therapeutics

Name

Title

Ms. Nancy Teasdale

Head of Regulatory Affairs

Mr. Eric J. Schoen

Chief Financial Officer

Mr. R. Christopher Cook J.D.

Chief Operating & Legal Officer

Mr. Michael Zamloot

Senior Vice President of Technical Operations

Mr. Jack Moore Ph.D.

Senior Vice President of Clinical Development

Dr. Joseph Hulihan M.D.

Chief Medical Officer

Mr. Richard Jon Barry

CEO, President & Director

Dr. George Thornton Ph.D.

Senior Vice President of Technology

Jaren Landen

Chief Clinical Development Officer

Dr. Angelique Bordey Ph.D.

Senior Vice President of Neuroscience

FAQs

What is Filana Therapeutics share price today?

Filana Therapeutics share price today is $0.71 as on at the close of the market. Filana Therapeutics share today touched a day high of $0.76 and a low of $0.70.

What is the 52 week high and 52 week low for Filana Therapeutics share?

Filana Therapeutics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Filana Therapeutics stock price today i.e. is closed at $0.71,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Filana Therapeutics's market capitalisation today?

Filana Therapeutics market capitalisation is $0.00T as on .

How to invest in Filana Therapeutics Stock (FLNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Filana Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Filana Therapeutics Stock (FLNA) from India?

Indian investors can start investing in Filana Therapeutics (FLNA) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Filana Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Filana Therapeutics share’s latest price of $0.71 as on October 17, 2026 at 1:29 am IST, you will get 14.1044 shares of Filana Therapeutics. Learn more about fractional shares .